MESENCHYMAL CHONDROSARCOMA

Clinical trials for MESENCHYMAL CHONDROSARCOMA explained in plain language.

Never miss a new study

Get alerted when new MESENCHYMAL CHONDROSARCOMA trials appear

Sign up with your email to follow new studies for MESENCHYMAL CHONDROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2

New drug trial targets rare, aggressive bone cancer

Disease control Recruiting now

This study is testing whether the drug trabectedin can help control advanced mesenchymal chondrosarcoma, a rare and aggressive type of bone and soft tissue cancer. It is for patients aged 16 and older whose cancer has continued to grow despite prior chemotherapy. The main goal is…

Matched conditions: MESENCHYMAL CHONDROSARCOMA

Phase: PHASE2 • Sponsor: Italian Sarcoma Group • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

MESENCHYMAL CHONDROSARCOMA

Get alerted when new MESENCHYMAL CHONDROSARCOMA trials appear

New drug trial targets rare, aggressive bone cancer